SCHEMBL1471487

SCHEMBL1471487

CC(=O)N(c1ccccc1)c1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.54
KMT2A Q03164 5/20 0.50
MEN1 O00255 3/20 0.50
TSHR P16473 2/20 0.50
NPC1 O15118 2/20 0.49
APAF1 O14727 2/20 0.49
ALDH1A1 P00352 5/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
POLB P06746 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13854618 0.94 NPSR1 (0.48) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL14571066 0.94 NPSR1 (0.48) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL8044893 0.93 NPSR1 (0.61) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL741752 0.91 NPSR1 (0.64) NPSR1KMT2AMEN1TSHRNPC1
Hydrochloric Acid SCHEMBL8550497 0.89 NPSR1 (0.61) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL3975700 0.85 NPSR1 (0.52) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL5540103 0.85 NPSR1 (0.52) NPSR1KMT2AMEN1TSHRNPC1
Acetic Acid SCHEMBL21145121 0.84 ALDH1A1 (0.54) NPSR1KMT2AMEN1TSHRNPC1
Acetone SCHEMBL11330473 0.84 ALDH1A1 (0.54) NPSR1KMT2AMEN1TSHRNPC1
SCHEMBL8009586 0.83 NPSR1 (0.50) NPSR1KMT2AMEN1TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7914911-B2 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-29 US disclosed
US-7914911-B2 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-29 US disclosed
US-7914911-B2 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-29 US disclosed
US-7646010-B2 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-01-12 US disclosed
US-7646010-B2 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-01-12 US disclosed
US-7646010-B2 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-01-12 US disclosed
US-20090200917-A1 ANTHRACENE DERIVATIVE AND LIGHT EMITTING ELEMENT AND LIGHT EMITTING DEVICE USING THE SAME SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-08-13 US disclosed
US-20090200917-A1 ANTHRACENE DERIVATIVE AND LIGHT EMITTING ELEMENT AND LIGHT EMITTING DEVICE USING THE SAME SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-08-13 US disclosed
US-20090200917-A1 ANTHRACENE DERIVATIVE AND LIGHT EMITTING ELEMENT AND LIGHT EMITTING DEVICE USING THE SAME SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-08-13 US disclosed
US-7541099-B2 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-06-02 US disclosed
US-7541099-B2 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-06-02 US disclosed
US-20070249867-A1 Method for Synthesis of Aromatic Amine SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249867-A1 Method for Synthesis of Aromatic Amine SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249867-A1 Method for Synthesis of Aromatic Amine SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-10-25 US disclosed
US-20070152572-A1 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-07-05 US disclosed
US-20070152572-A1 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-07-05 US disclosed
US-20070152572-A1 Light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-07-05 US disclosed
WO-2006057420-A1 LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2006-06-01 WO disclosed
WO-2006016684-A1 METHOD FOR SYNTHESIS OF AROMATIC AMINE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2006-02-16 WO disclosed
US-20050260450-A1 Anthracene derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200917-A1 ANTHRACENE DERIVATIVE AND LIGHT EMITTING ELEMENT AND LIGHT EMITTING DEVICE USING THE SAME CYBA, APEX1, ATXN10 NPSR1 3293/4885KMT2A 3180/4885MEN1 1093/4885
US-20070249867-A1 Method for Synthesis of Aromatic Amine TYR, TH, HTR3B NPSR1 774/4885KMT2A 123/4885MEN1 2775/4885
US-20050260450-A1 Anthracene derivative and light emitting element and light emitting device using the same CYBA, APEX1, ATXN10 NPSR1 3293/4885KMT2A 3180/4885MEN1 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.